Facebook
Twitter
Telegram
Report an ErrorPacific Biosciences of California Financial Ratios 2011-2024 | PACB
Annual Financial Ratios Pacific Biosciences of California
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.6 | -6.5 | -23.0 | 145.7 | -8.5 | -9.0 | -3.3 | -5.7 | -25.5 | -8.6 | -5.8 | -1.5 | -2.1 |
P/S |
7.0 | 15.9 | 32.0 | 54.3 | 7.9 | 11.7 | 3.3 | 4.7 | 8.7 | 9.4 | 16.3 | 5.4 | 6.9 |
EPS |
-1.2 | -1.4 | -0.9 | 0.2 | -0.6 | -0.8 | -0.9 | -0.8 | -0.4 | -0.9 | -1.3 | -1.7 | -2.0 |
EV (Enterprise Value) |
2.28 B | 2.92 B | 4.93 B | 4.28 B | 779 M | 956 M | 347 M | 463 M | 832 M | 600 M | 500 M | 115 M | 200 M |
EBITDA per Share |
-1.27 | -1.33 | -1 | -0.59 | -0.594 | -0.694 | -0.77 | -0.756 | -0.641 | -0.832 | -1.15 | -1.57 | -1.93 |
EV/EBITDA |
-23.8 | -51.8 | -7.9 | -9.8 | -3.7 | -6.3 | -16.3 | -9.3 | -6.2 | -1.1 | -1.7 | ||
PEG |
-0.28 | -0.42 | -2.48 | -138.89 | -0.31 | -0.71 | 0.69 | 0.06 | -0.46 | -0.34 | -0.23 | -0.09 | -0.02 |
P/B |
2.0 | 3.6 | 5.3 | 12.8 | 13.0 | 8.1 | 3.5 | 5.0 | 11.0 | 10.3 | 6.6 | 1.3 | 1.2 |
P/CF |
-5.5 | -7.8 | -37.6 | 219.7 | -8.8 | -13.5 | -3.9 | -5.6 | -15.9 | -10.7 | -14.9 | -1.8 | -2.1 |
ROE % |
-43.74 | -55.83 | -22.91 | 8.76 | -153.20 | -89.92 | -107.07 | -87.84 | -43.10 | -120.40 | -114.62 | -86.36 | -57.13 |
ROA % |
-17.57 | -17.78 | -9.03 | 7.10 | -56.85 | -60.23 | -63.98 | -53.94 | -24.18 | -53.13 | -58.22 | -72.84 | -50.11 |
ROCE % |
-47.69 | -54.57 | -26.60 | -31.11 | -101.73 | -70.43 | -77.77 | -68.43 | -56.15 | -67.56 | -68.24 | -82.08 | -55.17 |
Current Ratio |
1.7 | 1.5 | 1.7 | 5.3 | 1.6 | 4.9 | 3.5 | 3.2 | 2.9 | 3.7 | 5.6 | 7.8 | 10.3 |
DSO |
50.4 | 61.2 | 57.4 | 74.3 | 61.3 | 39.9 | 52.5 | 66.1 | 60.0 | 20.5 | 35.6 | 39.6 | 49.1 |
DIO |
132.2 | 172.6 | 98.9 | 108.5 | 86.3 | 121.9 | 143.2 | 122.6 | 101.7 | 111.2 | 168.6 | 139.8 | 271.9 |
DPO |
33.5 | 53.0 | 37.1 | 47.1 | 54.2 | 45.9 | 56.4 | 65.5 | 44.1 | 55.0 | 28.8 | 43.5 | 83.1 |
Operating Cycle |
182.7 | 233.8 | 156.3 | 182.8 | 147.6 | 161.8 | 195.6 | 188.6 | 161.6 | 131.8 | 204.1 | 179.4 | 321.0 |
Cash Conversion Cycle |
149.2 | 180.8 | 119.2 | 135.7 | 93.3 | 115.9 | 139.2 | 123.1 | 117.6 | 76.7 | 175.3 | 135.9 | 237.9 |
All numbers in USD currency
Quarterly Financial Ratios Pacific Biosciences of California
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.29 | - | -0.26 | -0.28 | -0.36 | - | -0.34 | -0.32 | -0.37 | - | 0.08 | -0.21 | -0.45 | - | -0.14 | -0.15 | 0.01 | - | -0.19 | -0.16 | -0.2 | - | -0.19 | -0.17 | -0.2 | - | -0.19 | -0.26 | -0.26 | - | -0.19 | -0.21 | -0.23 | -0.02 | 0.02 | -0.16 | -0.27 | - | -0.13 | -0.27 | -0.28 | - | -0.31 | -0.33 | -0.37 | - | -0.41 | -0.4 | -0.5 | - | -0.54 | -0.42 | -0.66 |
EBITDA per Share |
-0.29 | - | - | - | -0.37 | - | -0.3 | -0.28 | -0.34 | - | -0.34 | -0.17 | -0.16 | - | -0.12 | -0.13 | -0.2 | -117 | -148 | -136 | -0.19 | -205 | -0.14 | -0.14 | -0.18 | -0.18 | -0.13 | -0.2 | -0.22 | -0.19 | -0.15 | -0.18 | -0.21 | -0.01 | 0.07 | -0.13 | -0.25 | -0.24 | -0.07 | -227 | -0.25 | -0.26 | -0.24 | -0.28 | -0.33 | -0.39 | -0.31 | -0.34 | -0.47 | - | 0.08 | 53.5 | -0.61 |
ROE % |
-40.43 | -32.35 | -44.63 | -48.16 | -47.76 | -33.85 | -31.88 | -17.63 | -23.04 | -45.07 | -52.14 | -61.18 | -52.18 | -13.57 | -13.74 | -59.70 | -97.61 | -153.20 | -180.04 | -148.96 | -123.94 | -89.92 | -87.03 | -90.65 | -100.55 | -107.07 | -105.43 | -100.52 | -92.71 | -87.84 | -67.28 | -44.14 | -38.53 | -43.10 | -75.72 | -94.87 | -113.46 | -120.40 | -110.78 | -123.72 | -118.48 | -114.62 | -109.52 | -100.69 | -91.65 | -86.36 | -81.85 | -76.36 | -67.54 | -45.21 | -15.29 | -11.74 | -18.18 |
ROA % |
-15.51 | -11.94 | -16.17 | -16.88 | -16.91 | -12.25 | -11.43 | -6.39 | -5.87 | -9.46 | -15.18 | -21.72 | -24.01 | -11.00 | -11.06 | -25.01 | -36.06 | -56.85 | -74.88 | -69.91 | -66.52 | -60.23 | -56.56 | -57.13 | -61.62 | -63.98 | -63.37 | -60.78 | -56.47 | -53.94 | -41.21 | -27.14 | -22.82 | -24.18 | -38.36 | -47.10 | -53.37 | -53.15 | -50.55 | -58.23 | -57.89 | -58.22 | -62.28 | -64.76 | -67.07 | -72.84 | -69.55 | -65.43 | -58.39 | -39.65 | -13.41 | -10.29 | -15.94 |
ROCE % |
-45.54 | -35.38 | -47.29 | -48.40 | -46.97 | -32.43 | -41.29 | -38.24 | -42.82 | -35.42 | -42.63 | -40.98 | -33.44 | -23.97 | -56.59 | -100.58 | -137.96 | -183.09 | -177.31 | -147.74 | -122.41 | -88.54 | -85.53 | -88.95 | -98.21 | -104.28 | -101.54 | -96.26 | -89.28 | -84.15 | -64.48 | -41.16 | -35.26 | -39.62 | -70.74 | -89.60 | -107.46 | -114.39 | -106.40 | -119.91 | -115.50 | -112.09 | -107.34 | -99.17 | -90.88 | -86.25 | -66.41 | -45.77 | -43.41 | -36.53 | - | - | -18.26 |
Current Ratio |
1.6 | 1.7 | 1.7 | 1.5 | 1.6 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.7 | 1.3 | 1.3 | 5.3 | 5.3 | 5.3 | 5.3 | 1.6 | 1.6 | 1.6 | 1.6 | 3.0 | 3.0 | 3.0 | 3.0 | 2.5 | 2.5 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.6 | 2.3 | 2.3 | 2.3 | 2.3 | 1.8 | 1.8 | 1.8 | 1.8 | 2.0 | 2.0 | 2.0 | 2.0 | 6.4 | 6.4 | 6.4 | 6.4 | 8.1 | 8.1 | 8.1 | 8.1 |
DSO |
78.7 | - | 44.7 | 51.4 | 56.7 | - | 70.3 | 70.6 | 71.7 | - | 57.4 | 49.0 | 46.8 | - | 80.5 | 80.5 | 93.9 | 49.9 | 63.6 | 56.6 | 66.3 | 40.2 | 43.2 | 36.4 | 51.9 | 49.2 | 52.1 | 61.1 | 45.5 | 40.5 | 41.5 | 50.2 | 39.8 | 13.2 | 34.4 | 19.2 | 22.4 | 18.4 | 15.1 | 27.2 | 24.1 | 27.4 | 33.8 | 41.4 | 45.5 | 43.8 | 92.8 | 35.3 | 33.5 | - | 39.5 | 39.1 | - |
DIO |
205.6 | - | 164.0 | 184.6 | 175.9 | - | 193.6 | 155.6 | 130.1 | - | 84.7 | 92.7 | 86.9 | - | 108.0 | 124.1 | 154.9 | - | 81.0 | 80.9 | 125.8 | - | 109.0 | 128.3 | 154.8 | - | 137.4 | 174.3 | 110.5 | - | 114.3 | 141.2 | 126.1 | - | 135.7 | 95.8 | 86.8 | - | 138.6 | 124.6 | 108.8 | - | 148.4 | 183.8 | 192.8 | - | 338.5 | 124.8 | 112.4 | - | 196.9 | 518.5 | - |
DPO |
59.8 | - | 39.4 | 48.3 | 46.1 | - | 62.6 | 72.2 | 68.6 | - | 22.7 | 22.3 | 20.1 | - | 27.2 | 31.2 | 67.2 | - | 50.9 | 50.9 | 60.9 | - | 41.1 | 48.3 | 59.9 | - | 54.2 | 68.7 | 49.8 | - | 61.1 | 75.5 | 62.1 | - | 58.8 | 41.5 | 40.3 | - | 68.6 | 61.7 | 37.3 | - | 25.4 | 31.4 | 46.2 | - | 105.4 | 38.9 | 34.6 | - | 60.2 | 158.4 | - |
Operating Cycle |
284.2 | - | 208.7 | 236.0 | 232.6 | - | 263.9 | 226.3 | 201.7 | - | 142.1 | 141.7 | 133.7 | - | 188.6 | 204.6 | 248.8 | 49.9 | 144.5 | 137.5 | 192.1 | 40.2 | 152.2 | 164.6 | 206.7 | 49.2 | 189.5 | 235.4 | 156.0 | 40.5 | 155.8 | 191.4 | 165.8 | 13.2 | 170.1 | 115.0 | 109.2 | 18.4 | 153.7 | 151.8 | 132.9 | 27.4 | 182.2 | 225.2 | 238.3 | 43.8 | 431.2 | 160.1 | 146.0 | - | 236.4 | 557.6 | - |
Cash Conversion Cycle |
224.5 | - | 169.3 | 187.7 | 186.6 | - | 201.3 | 154.1 | 133.1 | - | 119.4 | 119.4 | 113.6 | - | 161.4 | 173.4 | 181.6 | 49.9 | 93.6 | 86.6 | 131.2 | 40.2 | 111.1 | 116.3 | 146.9 | 49.2 | 135.3 | 166.7 | 106.2 | 40.5 | 94.7 | 115.9 | 103.7 | 13.2 | 111.3 | 73.5 | 68.8 | 18.4 | 85.1 | 90.2 | 95.7 | 27.4 | 156.8 | 193.8 | 192.2 | 43.8 | 325.8 | 121.2 | 111.3 | - | 176.3 | 399.1 | - |
All numbers in USD currency